Zenotech Laboratories Limited (BOM:532039)
India flag India · Delayed Price · Currency is INR
39.00
+0.73 (1.91%)
At close: Nov 9, 2026

Zenotech Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
370.2401.63390.98368.09390.09329.47
Revenue Growth
-8.20%2.72%6.22%-5.64%18.40%69.51%
Gross Profit
334.72366.15347.75337.2360.75298.98
Operating Income
-33.2327.5673.61102.23141.88109.43
Net Income
-42.54-10.7256.1382.99115.85221.76
Earnings Per Share
-0.65-0.180.921.361.903.63
EPS Growth
---32.36%-28.37%-47.71%-

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
286.76304.24267.02196.88111.4224.15
Total Debt
-----60
Net Cash (Debt)
286.76304.24267.02196.88111.42-35.85
Net Cash Growth
-9.64%13.94%35.63%76.69%--
Net Cash Per Share
4.364.994.383.231.83-0.59

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
52.6102.0595.45118.23206.64176.67
Capital Expenditures
-100.17-83.22-39.2-42.34-62.32-19.38
Free Cash Flow
-47.5718.8356.2575.89144.33157.3
Free Cash Flow Growth
--66.53%-25.88%-47.42%-8.25%1796.31%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
90.42%91.16%88.94%91.61%92.48%90.75%
Operating Margin
-8.97%6.86%18.83%27.77%36.37%33.21%
Pretax Margin
-6.40%10.43%27.35%30.27%37.18%30.05%
Profit Margin
-11.49%-2.67%14.36%22.55%29.70%67.31%
FCF Margin
-12.85%4.69%14.39%20.62%37.00%47.74%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--56.4543.4724.7913.86
P/FCF Ratio
-111.1756.3347.5419.9019.54
PS Ratio
6.435.218.109.807.369.33